HemaSphere
(Jun 2022)
P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM
- E. Khan,
- J. Nourse,
- S. Tokalov,
- S. Khokhar,
- D. Arnold-Schild,
- L. Schott,
- L. Eder,
- S. Danckwardt
Affiliations
- E. Khan
- 1 Center for Thrombosis and Hemostasis
- J. Nourse
- 1 Center for Thrombosis and Hemostasis
- S. Tokalov
- 1 Center for Thrombosis and Hemostasis
- S. Khokhar
- 1 Center for Thrombosis and Hemostasis
- D. Arnold-Schild
- 2 Johannes Gutenberg-University Medical Center Mainz, Mainz, Germany
- L. Schott
- 1 Center for Thrombosis and Hemostasis
- L. Eder
- 1 Center for Thrombosis and Hemostasis
- S. Danckwardt
- 1 Center for Thrombosis and Hemostasis
- DOI
-
https://doi.org/10.1097/01.HS9.0000849612.93722.61
- Journal volume & issue
-
Vol. 6
pp.
1570
– 1571
WeChat QR code